- Home
- CHCT vs MAZE Comparison
CHCT vs MAZE Comparison
Compare CHCT & MAZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHCT
- MAZE
- Stock Information
- Founded
- CHCT 2014
- MAZE 2018
- Country
- CHCT United States
- MAZE United States
- Employees
- CHCT N/A
- MAZE N/A
- Industry
- CHCT Real Estate Investment Trusts
- MAZE
- Sector
- CHCT Real Estate
- MAZE
- Exchange
- CHCT Nasdaq
- MAZE NYSE
- Market Cap
- CHCT 422.2M
- MAZE 367.0M
- IPO Year
- CHCT 2015
- MAZE 2025
- Fundamental
- Price
- CHCT $16.17
- MAZE $9.62
- Analyst Decision
- CHCT Buy
- MAZE Strong Buy
- Analyst Count
- CHCT 4
- MAZE 3
- Target Price
- CHCT $21.25
- MAZE $25.67
- AVG Volume (30 Days)
- CHCT 205.2K
- MAZE 218.3K
- Earning Date
- CHCT 04-29-2025
- MAZE 01-01-0001
- Dividend Yield
- CHCT 11.56%
- MAZE N/A
- EPS Growth
- CHCT N/A
- MAZE N/A
- EPS
- CHCT N/A
- MAZE 1.25
- Revenue
- CHCT $116,531,000.00
- MAZE $167,500,000.00
- Revenue This Year
- CHCT $8.02
- MAZE N/A
- Revenue Next Year
- CHCT $8.13
- MAZE N/A
- P/E Ratio
- CHCT N/A
- MAZE $7.75
- Revenue Growth
- CHCT 1.33
- MAZE N/A
- 52 Week Low
- CHCT $14.76
- MAZE $6.71
- 52 Week High
- CHCT $27.62
- MAZE $17.00
- Technical
- Relative Strength Index (RSI)
- CHCT 41.92
- MAZE N/A
- Support Level
- CHCT $16.79
- MAZE N/A
- Resistance Level
- CHCT $17.29
- MAZE N/A
- Average True Range (ATR)
- CHCT 0.47
- MAZE 0.00
- MACD
- CHCT 0.12
- MAZE 0.00
- Stochastic Oscillator
- CHCT 32.16
- MAZE 0.00
About CHCT Community Healthcare Trust Incorporated
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.
About MAZE MAZE THERAPEUTICS INC
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.